Intravenous (IV) Iron Therapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 65 pages | ID: I3281EE44907EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Intravenous (IV) Iron Therapy in Global, including the following market information:

Global Intravenous (IV) Iron Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Intravenous (IV) Iron Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Ferric Carboxymaltose Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intravenous (IV) Iron Therapy include Sanofi, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Intravenous (IV) Iron Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intravenous (IV) Iron Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Intravenous (IV) Iron Therapy Market Segment Percentages, by Type, 2021 (%)

• Ferric Carboxymaltose
• Iron Sucrose
• Iron Dextran
• Others

Global Intravenous (IV) Iron Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Intravenous (IV) Iron Therapy Market Segment Percentages, by Application, 2021 (%)

• Nephrology
• Gynecology & Obstetrics
• Gastroenterology
• Oncology
• Cardiology
• Others

Global Intravenous (IV) Iron Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Intravenous (IV) Iron Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intravenous (IV) Iron Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Intravenous (IV) Iron Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Allergan
• AMAG Pharmaceuticals
• Dalichi Sankyo
• Luitpold Pharmaceuticals
• Pharmacosmos
• Takeda Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Intravenous (IV) Iron Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Intravenous (IV) Iron Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL INTRAVENOUS (IV) IRON THERAPY OVERALL MARKET SIZE

2.1 Global Intravenous (IV) Iron Therapy Market Size: 2021 VS 2028
2.2 Global Intravenous (IV) Iron Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Intravenous (IV) Iron Therapy Players in Global Market
3.2 Top Global Intravenous (IV) Iron Therapy Companies Ranked by Revenue
3.3 Global Intravenous (IV) Iron Therapy Revenue by Companies
3.4 Top 3 and Top 5 Intravenous (IV) Iron Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Intravenous (IV) Iron Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Intravenous (IV) Iron Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Intravenous (IV) Iron Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Intravenous (IV) Iron Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Intravenous (IV) Iron Therapy Market Size Markets, 2021 & 2028
  4.1.2 Ferric Carboxymaltose
  4.1.3 Iron Sucrose
  4.1.4 Iron Dextran
  4.1.5 Others
4.2 By Type - Global Intravenous (IV) Iron Therapy Revenue & Forecasts
  4.2.1 By Type - Global Intravenous (IV) Iron Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Intravenous (IV) Iron Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Intravenous (IV) Iron Therapy Market Size, 2021 & 2028
  5.1.2 Nephrology
  5.1.3 Gynecology & Obstetrics
  5.1.4 Gastroenterology
  5.1.5 Oncology
  5.1.6 Cardiology
  5.1.7 Others
5.2 By Application - Global Intravenous (IV) Iron Therapy Revenue & Forecasts
  5.2.1 By Application - Global Intravenous (IV) Iron Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Intravenous (IV) Iron Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Intravenous (IV) Iron Therapy Market Size, 2021 & 2028
6.2 By Region - Global Intravenous (IV) Iron Therapy Revenue & Forecasts
  6.2.1 By Region - Global Intravenous (IV) Iron Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Intravenous (IV) Iron Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Intravenous (IV) Iron Therapy Revenue, 2017-2028
  6.3.2 US Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.3.3 Canada Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.3.4 Mexico Intravenous (IV) Iron Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Intravenous (IV) Iron Therapy Revenue, 2017-2028
  6.4.2 Germany Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.4.3 France Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.4.4 U.K. Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.4.5 Italy Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.4.6 Russia Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.4.8 Benelux Intravenous (IV) Iron Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Intravenous (IV) Iron Therapy Revenue, 2017-2028
  6.5.2 China Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.5.3 Japan Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.5.4 South Korea Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.5.6 India Intravenous (IV) Iron Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Intravenous (IV) Iron Therapy Revenue, 2017-2028
  6.6.2 Brazil Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.6.3 Argentina Intravenous (IV) Iron Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue, 2017-2028
  6.7.2 Turkey Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.7.3 Israel Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Intravenous (IV) Iron Therapy Market Size, 2017-2028
  6.7.5 UAE Intravenous (IV) Iron Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Intravenous (IV) Iron Therapy Major Product Offerings
  7.1.4 Sanofi Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Intravenous (IV) Iron Therapy Major Product Offerings
  7.2.4 Allergan Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 AMAG Pharmaceuticals
  7.3.1 AMAG Pharmaceuticals Corporate Summary
  7.3.2 AMAG Pharmaceuticals Business Overview
  7.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Major Product Offerings
  7.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.3.5 AMAG Pharmaceuticals Key News
7.4 Dalichi Sankyo
  7.4.1 Dalichi Sankyo Corporate Summary
  7.4.2 Dalichi Sankyo Business Overview
  7.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Major Product Offerings
  7.4.4 Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.4.5 Dalichi Sankyo Key News
7.5 Luitpold Pharmaceuticals
  7.5.1 Luitpold Pharmaceuticals Corporate Summary
  7.5.2 Luitpold Pharmaceuticals Business Overview
  7.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Major Product Offerings
  7.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.5.5 Luitpold Pharmaceuticals Key News
7.6 Pharmacosmos
  7.6.1 Pharmacosmos Corporate Summary
  7.6.2 Pharmacosmos Business Overview
  7.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Major Product Offerings
  7.6.4 Pharmacosmos Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.6.5 Pharmacosmos Key News
7.7 Takeda Pharmaceutical
  7.7.1 Takeda Pharmaceutical Corporate Summary
  7.7.2 Takeda Pharmaceutical Business Overview
  7.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Major Product Offerings
  7.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue in Global Market (2017-2022)
  7.7.5 Takeda Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Intravenous (IV) Iron Therapy Market Opportunities & Trends in Global Market
Table 2. Intravenous (IV) Iron Therapy Market Drivers in Global Market
Table 3. Intravenous (IV) Iron Therapy Market Restraints in Global Market
Table 4. Key Players of Intravenous (IV) Iron Therapy in Global Market
Table 5. Top Intravenous (IV) Iron Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Intravenous (IV) Iron Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Intravenous (IV) Iron Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Intravenous (IV) Iron Therapy Product Type
Table 9. List of Global Tier 1 Intravenous (IV) Iron Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Intravenous (IV) Iron Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Intravenous (IV) Iron Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Intravenous (IV) Iron Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Intravenous (IV) Iron Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Intravenous (IV) Iron Therapy Product Offerings
Table 32. Sanofi Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Intravenous (IV) Iron Therapy Product Offerings
Table 35. Allergan Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)
Table 36. AMAG Pharmaceuticals Corporate Summary
Table 37. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Product Offerings
Table 38. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Dalichi Sankyo Corporate Summary
Table 40. Dalichi Sankyo Intravenous (IV) Iron Therapy Product Offerings
Table 41. Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Luitpold Pharmaceuticals Corporate Summary
Table 43. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Product Offerings
Table 44. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Pharmacosmos Corporate Summary
Table 46. Pharmacosmos Intravenous (IV) Iron Therapy Product Offerings
Table 47. Pharmacosmos Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Takeda Pharmaceutical Corporate Summary
Table 49. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Product Offerings
Table 50. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Intravenous (IV) Iron Therapy Segment by Type in 2021
Figure 2. Intravenous (IV) Iron Therapy Segment by Application in 2021
Figure 3. Global Intravenous (IV) Iron Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Intravenous (IV) Iron Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Intravenous (IV) Iron Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2021
Figure 8. By Type - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 12. US Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 24. China Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Intravenous (IV) Iron Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Intravenous (IV) Iron Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pharmacosmos Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)